Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Investor Eye

Set Alert for Investor Eye

Investor Eye: Juno Capital Believes Medtech Is An Optimal Long-Term Investment

Juno Capital partner Edward Rudd believes that investing in medtech offers not only a long-term strategy for allocating capital, but an altruistic relief for investors.

Investor Eye Financing Digital Health

Investor Eye: Juno Capital Believes Medtech Is An Optimal Long-Term Investment

Juno Capital partner Edward Rudd believes that investing in medtech offers not only a long-term strategy for allocating capital, but an altruistic relief for investors.

Investor Eye Financing

Investor Eye: Endeavour Vision Highlights Humanity Of Medtech, Invests In Unmet Needs

Unmet needs are at the core of Endeavour Vision’s investment strategy, accepting that payment models may need to change as patients become more directly involved in device development.

Investor Eye Diabetic Care

Investor Eye: Novalis Embraces Early Investment And Enabling Technology

Novalis Biotech employs early targeted investments to produce returns, focusing on enabling technologies and risky ventures in diagnostics and digital health.

Investor Eye Business Strategies

Investor Eye: Octopus Ventures Tackles Tough, Taboo Problems In Health Care

In an interview with Medtech Insight, Octopus Ventures partner Pooja Sikka explained the approach Octopus takes to investments, and the key challenges the fund wants to address.

Investor Eye Financing

Investor Eye: Claudio D’Angelo Of RYSE Asset Management Explains Early-Stage Digital Health Investment

RYSE head tells Medtech Insight about his firm’s shift to investing in virtual primary care and telemedicine.

Investor Eye Digital Health

Investor Eye: Kyp Sirinakis, Epidarex Capital – ‘The Innovation Hunter’

In this edition of Investor Eye, Medtech Insight spoke to Kyp Sirinakis, managing partner at Epidarex Capital, a transatlantic fund investing in emerging life science hubs in the US and UK. The firm recently launched a new UK fund, Epidarex Capital III, for innovative UK start-ups.

Investor Eye Innovation

Investor Eye: Sergey Young Searches For Investments That Extend Life

Sergey Young is on a mission to "extend healthy lifespans" by investing in longevity breakthroughs. Last year, the venture capitalist established a $100m fund investing in technologies with the potential to improve healthy long living.

Investor Eye Financing

Investor Eye: Howard Rowe, Hayfin Capital Management – The Specialized Health Care Lenders

In this edition of Investor Eye, Medtech Insight meets with Howard Rowe, managing director and head of health care at Hayfin Capital Management, a $17bn international asset management firm headquartered in London.

Investor Eye Financing

Investor Eye: Israel’s Medical Device Fund Accelmed Seizes On Slow Medtech Investing

Israeli healthtech fund Accelmed is seizing the opportunity to implement a medtech-investment strategy that is delivering big returns. In this Medtech Insight feature, Irit Yaniv, partner at Israeli VC Accelmed, discusses changing trends in the medtech VC industry and the hot new areas of medical technology coming out of Israel.

Investor Eye Israel
See All
UsernamePublicRestriction

Register